Key result
KCNK17 gene variations are linked to higher risk of arrhythmias, heart failure, and stroke.
Why the study?
Pure electrical heart diseases cause a large number of sudden cardiac deaths in patients without structural or functional heart abnormalities, but their molecular basis requires review.
Systematic Review (n=8,159)
KCNK17 variants may link to arrhythmia risk; leaves open clinical utility pending replication and prospective validation.
Sudden cardiac death occurs in a minority of patients in the absence of structural or functional abnormalities. In this category, pure electrical heart diseases are responsible for a large number of these unexpected deaths. These conditions include the long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome (collectively referred to as channelopathies) and idiopathic ventricular fibrillation. This article reviews the current molecular understanding of the electrical diseases of the heart associated with sudden cardiac death, and provides a summary of the causal genes and a flowchart with an overview of the genotype-phenotype correlation of the most common arrhythmia syndromes.
No takes yet. Share an insight, caveat, or question.
Hofman et al. (2010) conducted a systematic review in Cardiovascular and cerebrovascular diseases (n=8,159). KCNK17 mutations and polymorphisms vs. Wild-type KCNK17 or absence of mutation/polymorphism was evaluated on Association of KCNK17 mutations/polymorphisms with cardiovascular and cerebrovascular diseases. Specific nucleotide variations in the KCNK17 gene are associated with cardiovascular and cerebrovascular diseases, including atrial fibrillation, ventricular arrhythmias, heart failure, and ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: